Transition to chronic pain: opportunities for novel therapeutics
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Although chronic pain is one of the most important medical problems facing society, there has been very limited progress in the development of novel therapies for this condition. Here, we discuss high-impact research priorities to reduce the number of people transitioning from acute to chronic intractable pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pain regulation by non-neuronal cells and inflammation
Ji, R.-R., Chamessian, A., & Zhang, Y.-Q. (2016) · Science · doi:10.1126/science.aaf8924 · Cited by 1,314
Self-citationPain vulnerability: a neurobiological perspective
Denk, F., McMahon, S. B., & Tracey, I. (2014) · Nature Neuroscience · doi:10.1038/nn.3628 · Cited by 363
Cited by
Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain
Donnelly, C. R., Andriessen, A. S., Chen, G., Wang, K., Jiang, C., Maixner, W., & Ji, R.-R. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00905-7 · Cited by 301
Self-citationMacrophages transfer mitochondria to sensory neurons to resolve inflammatory pain
van der Vlist, M., Raoof, R., Willemen, H. L. D. M., Prado, J., Versteeg, S., Martin Gil, C., Vos, M., Lokhorst, R. E., Pasterkamp, R. J., Kojima, T., et al. (2022) · Neuron · doi:10.1016/j.neuron.2021.11.020 · Cited by 255
Katz, J., Weinrib, A. Z., & Clarke, H. (2019) · Canadian Journal of Pain · doi:10.1080/24740527.2019.1574537 · Cited by 87
Self-citationB cells drive neuropathic pain–related behaviors in mice through IgG–Fc gamma receptor signaling
Lacagnina, M. J., Willcox, K. F., Boukelmoune, N., Bavencoffe, A., Sankaranarayanan, I., Barratt, D. T., Zuberi, Y. A., Dayani, D., Chavez, M. V., Lu, J. T., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj1277 · Cited by 60
“The enduring effect of a single injection of anti-CD20 mAb suggests that immunotherapies modifying the B cell–IgG–Fc γ R signaling axis may prevent chronic neuropathic pain, which is a high priority for novel pain therapeutics ( 40 ).”
BackgroundSelf-citationRosenbloom, B. N., & Katz, J. (2022) · Canadian Journal of Pain · doi:10.1080/24740527.2022.2059754 · Cited by 28
Self-citation
Metadata
- Authors
- Price, T. J., Basbaum, A. I., Bresnahan, J., Chambers, J. F., De Koninck, Y., Edwards, R. R., Ji, R.-R., Katz, J., Kavelaars, A., Levine, J. D., Porter, L., Schechter, N., Sluka, K. A., Terman, G. W., Wager, T. D., Yaksh, T. L., & Dworkin, R. H.
- Venue
- Nature Reviews Neuroscience
- Published
- 2018-05-15
- Volume
- 19
- Issue
- 7
- Pages
- 383-384
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2803929023
- Cited by
- 157
- References
- 2
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transition to chronic pain: opportunities for novel therapeutics. https://app.cochat.ai/papers/10.1038/s41583-018-0012-5
- The paper
- Price, T. J., Basbaum, A. I., Bresnahan, J., Chambers, J. F., De Koninck, Y., Edwards, R. R., Ji, R.-R., Katz, J., Kavelaars, A., Levine, J. D., Porter, L., Schechter, N., Sluka, K. A., Terman, G. W., Wager, T. D., Yaksh, T. L., & Dworkin, R. H. (2018). Transition to chronic pain: opportunities for novel therapeutics. Nature Reviews Neuroscience. https://doi.org/10.1038/s41583-018-0012-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.